Literature DB >> 2385122

Reoperative coronary surgery. Comparative analysis of 6591 patients undergoing primary bypass and 508 patients undergoing reoperative coronary artery bypass.

N W Salomon1, U S Page, J C Bigelow, A H Krause, J E Okies, M T Metzdorff.   

Abstract

During an 18-year period a consecutive series of 6591 patients underwent primary coronary bypass grafting and 508 patients underwent reoperative bypass. The mean patient age for the reoperative group was identical to that of the primary group, 59.8 years, but the mean age at initial operation for the reoperative group was 55.2 years. Mammary grafts were done at initial operation in 59% of patients who have had one operation versus only 46% of patients who subsequently required reoperation (p less than 0.001). The overall operative mortality rate was 2.0% (134/6591) for primary coronary bypass versus 6.9% (35/508) for reoperations (p less than 0.001). Patients with a reoperative interval of 1 to 10 years had a 6.0% (18/312) mortality rate, compared with 17.6% (13/74) for those in whom the interval between operations was greater than 10 years (p less than 0.01). Ventricular arrhythmias, excessive bleeding, prolonged ventilatory support, intraaortic balloon pump insertion (all p less than 0.05), and perioperative myocardial infarction (p less than 0.001) were all more prevalent after reoperations. Including perioperative mortality, the actuarial survival rate at 5 years was 80% for reoperations versus 90% for primary operations. The corresponding figures at 10 years were 65% and 75%. The probability of undergoing reoperation within 5 and 10 years was 0.034 +/- 0.003 and 0.055 +/- 0.005, respectively. Ten years postoperatively, 36% of patients having the initial operation had recurrent angina whereas 58% of the reoperative group had significant recurrent angina. Ten years after reoperation, 30% of operative survivors were free of heart-related morbidity and mortality compared with 50% of patients having a primary operation. Univariate analysis of factors increasing the probability of reoperation include the absence of a mammary graft and younger age at operation. Patients undergoing a second bypass operation represent a substantially higher risk subgroup than patients undergoing initial operation in terms of perioperative morbidity, mortality, decreased long-term survival, and decreased relief of recurrent cardiac morbidity.

Entities:  

Mesh:

Year:  1990        PMID: 2385122

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

1.  Cardiac CT for planning redo cardiac surgery: effect of knowledge-based iterative model reconstruction on image quality.

Authors:  Seitaro Oda; Gaby Weissman; Mani Vembar; Wm Guy Weigold
Journal:  Eur Radiol       Date:  2014-09-03       Impact factor: 5.315

2.  Evaluation of long-term quality of life after reoperative coronary artery surgery: preliminary results.

Authors:  L Noyez; A Schultz; S M van der Heide; F M van Eck; R M H J Brouwer
Journal:  Neth Heart J       Date:  2003-12       Impact factor: 2.380

3.  Relationship between routine multi-detector cardiac computed tomographic angiography prior to reoperative cardiac surgery, length of stay, and hospital charges.

Authors:  Matthew A Goldstein; Sion K Roy; Shinivas Hebsur; Gabriel Maluenda; Gaby Weissman; Guy Weigold; Marc J Landsman; Peter C Hill; Francisco Pita; Paul J Corso; Steven W Boyce; Augusto D Pichard; Ron Waksman; Allen J Taylor
Journal:  Int J Cardiovasc Imaging       Date:  2012-10-12       Impact factor: 2.357

4.  Mid-term outcomes of patients with PCI prior to CABG in comparison to patients with primary CABG.

Authors:  Sandra Eifert; Helmut Mair; Anne-Laure Boulesteix; Eckehard Kilian; Martin Adamczak; Bruno Reichart; Peter Lamm
Journal:  Vasc Health Risk Manag       Date:  2010-08-09

5.  Extension of the right internal thoracic artery with the radial artery in extensive re-do coronary artery bypass grafting.

Authors:  Felix Fleissner; Fabio Ius; Axel Haverich; Issam Ismail
Journal:  J Cardiothorac Surg       Date:  2013-07-12       Impact factor: 1.637

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.